Influenza Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type
This report describes the global market size of Influenza Vaccine from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030.
For geography segment, regional supply, demand, major players, price is presented from 2020 to 2030. This report cover following regions: North America South America Asia & Pacific Europe MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Influenza Vaccine as well as some small players. The information for each competitor include: Company Profile Main Business Information SWOT Analysis Sales Volume, Revenue, Price and Gross Margin Market Share
Types Segment: Inactivated Vaccine Live Vaccine
Companies Covered: KM Biologics Valneva GPO-MBP Co. Ltd. Biological E. Limited Chengdu Institute of Biological Products Co. Ltd etc.
Please ask for sample pages for full companies list
Base Year: 2025 Historical Data: from 2020 to 2024 Forecast Data: from 2025 to 2030
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Influenza Vaccine Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Influenza Vaccine by Region
8.2 Import of Influenza Vaccine by Region
8.3 Balance of Trade
Chapter 9 Historical and Forecast Influenza Vaccine Market in North America (2020-2030)
9.1 Influenza Vaccine Market Size
9.2 Influenza Vaccine Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Forecast Influenza Vaccine Market in South America (2020-2030)
10.1 Influenza Vaccine Market Size
10.2 Influenza Vaccine Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Forecast Influenza Vaccine Market in Asia & Pacific (2020-2030)
11.1 Influenza Vaccine Market Size
11.2 Influenza Vaccine Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southest Asia
11.5.6 Australia
Chapter 12 Historical and Forecast Influenza Vaccine Market in Europe (2020-2030)
12.1 Influenza Vaccine Market Size
12.2 Influenza Vaccine Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Forecast Influenza Vaccine Market in MEA (2020-2030)
13.1 Influenza Vaccine Market Size
13.2 Influenza Vaccine Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey
Chapter 14 Summary For Global Influenza Vaccine Market (2020-2025)
14.1 Influenza Vaccine Market Size
14.2 Influenza Vaccine Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Influenza Vaccine Market Forecast (2025-2030)
15.1 Influenza Vaccine Market Size Forecast
15.2 Influenza Vaccine Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
16.1 KM Biologics
16.1.1 Company Profile
16.1.2 Main Business and Influenza Vaccine Information
16.1.3 SWOT Analysis of KM Biologics
16.1.4 KM Biologics Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
16.2 Valneva
16.2.1 Company Profile
16.2.2 Main Business and Influenza Vaccine Information